Records containing: Onchocerciasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-02Early Detection and Management of SKIN-related negleCted Tropical Diseases Using Artificial Intelligence in Sub-saharan afRica (SkincAIr)
-
CLINICAL_TRIALS study record update · 2026-04-01Host Response to Infection and Treatment in the Filarial Diseases of Humans
-
CLINICAL_TRIALS study record update · 2026-02-05A Randomized, Double Blind, Parallel Group Clinical Trial to Evaluate the Safety of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Treatment With Albendazole
-
CLINICAL_TRIALS study record update · 2025-12-23A Randomized, Double Blind, Parallel Trial in the Democratic Republic of Congo (DRC) Comparing the Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Treatment of Onchocerciasis
-
CLINICAL_TRIALS study record update · 2025-12-18Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-25Integrating Mental Health and Neglected Tropical Disease Interventions to Support Equitable People-Centred Care in Ghana
-
CLINICAL_TRIALS study record update · 2025-11-21Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases: A Cluster-randomised Trial
-
CLINICAL_TRIALS study record update · 2025-03-25Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
-
CLINICAL_TRIALS study record update · 2025-03-07Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination
-
CLINICAL_TRIALS study record update · 2025-01-22An Open-label Study of the Pharmacokinetics and Safety of a Single Dose of Moxidectin Per Oral in Subjects Aged 4 to 17 Years With (or at Risk of) Onchocerciasis to Identify an Optimal Dose for Treatment of Children 4 to 11 Years
-
CLINICAL_TRIALS study record update · 2024-09-19A Phase-II, Randomised, Double-blind, Parallel-group, Proof-of-concept Trial to Investigate ABBV-4083 Given for 7 or 14 Days or in Combination With Albendazole in Subjects With Onchocerca Volvulus Infection, Comprising: Part 1 to Investigate Safety, Tolerability, Efficacy for Dose-Ranging and Pharmacokinetics; Part 2 to Investigate Efficacy of Selected Doses, Safety, Tolerability and Pharmacokinetics
-
CLINICAL_TRIALS study record update · 2024-08-15Trial of Rifampin and Azithromycin for Treatment of Endosymbiotic Bacteria (Wolbachia) in Onchocerca Volvulus in Guatemala
-
CLINICAL_TRIALS study record update · 2024-03-05A Phase-II, Randomised, Double-blind, Parallel-group Trial to Investigate Emodepside (BAY 44-4400) in Subjects With Onchocerca Volvulus Infection, Comprising: Part 1 to Investigate Safety, Tolerability, Pharmacodynamics, Pharmacokinetics and Dose-Response Relationship for Efficacy (Proof-of-Concept); Part 2 to Investigate Efficacy of Selected Doses, Safety, Tolerability and Pharmacokinetics
-
CLINICAL_TRIALS study record update · 2023-11-30Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan, a Three-year Prospective Study
-
CLINICAL_TRIALS study record update · 2023-11-28Impact of a Bi-annual Community-directed Treatment With Ivermectin Programme on the Incidence of Epilepsy in an Onchocerciasis-endemic Area of Mahenge, Tanzania: a Population-based Prospective Study
-
CLINICAL_TRIALS study record update · 2023-09-21Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug
-
CLINICAL_TRIALS study record update · 2023-05-10Safety and Efficacy of Combination Therapy With Ivermectin, Diethylcarbamazine, and Albendazole (IDA) for Individuals With Onchocerciasis
-
CLINICAL_TRIALS study record update · 2022-12-15A Randomized, Single-Ascending Dose, Ivermectin-Controlled, Double-Blind, Safety, Tolerability, Pharmacokinetic, and Efficacy Study Of Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection
-
CLINICAL_TRIALS study record update · 2022-02-11Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Liberia
-
CLINICAL_TRIALS study record update · 2020-12-31Microfilarial Clearance From the Eye and Ocular Changes Associated With Ivermectin Treatment in Individuals With Onchocerciasis
-
CLINICAL_TRIALS study record update · 2019-04-26Comparison of Ivermectin Alone With Albendazole (ALB) Plus Ivermectin (IVM) in Their Efficacy Against Onchocerciasis in the Volta Region, Ghana.
-
CLINICAL_TRIALS study record update · 2019-01-07Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2018-10-11Determination of the Prevalence of LF Infection in Districts Not Included in LF Control Activities and of the Basis for Integrated Implementation of LF - Onchocerciasis Elimination Strategies in Potentially Co-endemic Areas
-
CLINICAL_TRIALS study record update · 2018-08-31Clinical Features and Potential Etiology of Epilepsy and Nodding Syndrome in the Mahenge Area, Ulanga District
-
CLINICAL_TRIALS study record update · 2018-05-04Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast